Polymeric oral thin films (OTFs) were prepared by the casting method, combining gellan gum (GG), a water-soluble polysaccharide, and glycerol (Gly) as a plasticizing agent. GG-Gly films were investigated as potential systems for buccal drug delivery using fluconazole (Class I of the Biopharmaceutical Classification System) as a model drug. At a low concentration of Gly drug precipitation occurred while, for higher concentrations of Gly, a significant deterioration of mucoadhesive and mechanical properties was observed. One possible way to overcome all these problems could be the addition of hydroxypropyl-β-cyclodextrin (HP-β-CD) to the GG-Gly formulation as a drug-precipitation inhibitor. In this work the effect of cyclodextrin addition on the mechanical, mucoadhesive, swelling and release properties of GG-Gly films was investigated. In-vitro drug release studies were carried out using the paddle type dissolution apparatus (USP II) and the millifluidic flow-through device (MFTD). A moving-boundary model for swelling dynamics and release in USP II is proposed to estimate the effective diffusivity of the solvent, HP-β-CD, fluconazole and complex fluconazole/HP-β-CD in the swelling film. Experimental results, supported by theoretical modeling, confirmed that gellan gum-low glycerol thin films including HP-β-CD represent a suitable formulation for fluconazole drug delivery. A sustained release was observed when GG-Gly film is loaded with a preformed complex fluconazole/HP-β-CD.

Enhanced loading efficiency and mucoadhesion properties of gellan gum thin films by complexation with Hydroxypropyl-β-Cyclodextrin / Adrover, Alessandra; di Muzio, Laura; Trilli, Jordan; Brandelli, Chiara; Paolicelli, Patrizia; Petralito, Stefania; Casadei, Maria Antonietta. - In: PHARMACEUTICS. - ISSN 1999-4923. - 12:9(2020). [10.3390/pharmaceutics12090819]

Enhanced loading efficiency and mucoadhesion properties of gellan gum thin films by complexation with Hydroxypropyl-β-Cyclodextrin

Adrover, Alessandra
Primo
;
di Muzio, Laura;Trilli, Jordan;Brandelli, Chiara;Paolicelli, Patrizia
;
Petralito, Stefania;Casadei, Maria Antonietta
2020

Abstract

Polymeric oral thin films (OTFs) were prepared by the casting method, combining gellan gum (GG), a water-soluble polysaccharide, and glycerol (Gly) as a plasticizing agent. GG-Gly films were investigated as potential systems for buccal drug delivery using fluconazole (Class I of the Biopharmaceutical Classification System) as a model drug. At a low concentration of Gly drug precipitation occurred while, for higher concentrations of Gly, a significant deterioration of mucoadhesive and mechanical properties was observed. One possible way to overcome all these problems could be the addition of hydroxypropyl-β-cyclodextrin (HP-β-CD) to the GG-Gly formulation as a drug-precipitation inhibitor. In this work the effect of cyclodextrin addition on the mechanical, mucoadhesive, swelling and release properties of GG-Gly films was investigated. In-vitro drug release studies were carried out using the paddle type dissolution apparatus (USP II) and the millifluidic flow-through device (MFTD). A moving-boundary model for swelling dynamics and release in USP II is proposed to estimate the effective diffusivity of the solvent, HP-β-CD, fluconazole and complex fluconazole/HP-β-CD in the swelling film. Experimental results, supported by theoretical modeling, confirmed that gellan gum-low glycerol thin films including HP-β-CD represent a suitable formulation for fluconazole drug delivery. A sustained release was observed when GG-Gly film is loaded with a preformed complex fluconazole/HP-β-CD.
2020
thin films; drug delivery; gellan gum; cyclodextrins; USP II; millifluidic flow-through device; mathematical modeling
01 Pubblicazione su rivista::01a Articolo in rivista
Enhanced loading efficiency and mucoadhesion properties of gellan gum thin films by complexation with Hydroxypropyl-β-Cyclodextrin / Adrover, Alessandra; di Muzio, Laura; Trilli, Jordan; Brandelli, Chiara; Paolicelli, Patrizia; Petralito, Stefania; Casadei, Maria Antonietta. - In: PHARMACEUTICS. - ISSN 1999-4923. - 12:9(2020). [10.3390/pharmaceutics12090819]
File allegati a questo prodotto
File Dimensione Formato  
Adrover_Enhanced_2020.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 849.97 kB
Formato Adobe PDF
849.97 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1435467
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 9
social impact